Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

106.54
+2.332.24%
Post-market: 105.61-0.9264-0.87%18:05 EDT
Volume:9.63M
Turnover:1.01B
Market Cap:132.82B
PE:22.52
High:106.81
Open:105.33
Low:103.80
Close:104.21
Loading ...

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Yesterday

Gilead Sciences to Present at Upcoming Investor Conferences

Business Wire
·
Yesterday

Gilead Sciences to Pay $202 Million in Settlement of Illegal Kickbacks Lawsuit

MT Newswires Live
·
Yesterday

U.S. Attorney in Manhattan Announces $202 Mln Settlement With Gilead Sciences for Using Speaker Programs to Pay Kickbacks to Doctors

THOMSON REUTERS
·
Yesterday

Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors

Reuters
·
Yesterday

Gilead Sciences (NasdaqGS:GILD) Showcases Promising Liver Disease Treatments At EASL Congress

Simply Wall St.
·
Yesterday

Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States

ACCESS Newswire
·
29 Apr

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

Business Wire
·
29 Apr

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development

Business Wire
·
29 Apr

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks

Dow Jones
·
28 Apr

Gilead Sciences First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.
·
26 Apr

Gilead Sciences’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
26 Apr

Gilead Sciences Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
26 Apr

Gilead Delivers Lackluster Q1 Revenue on Trodelvy Miss, Oppenheimer Says

MT Newswires Live
·
25 Apr

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-04-25

Reuters
·
25 Apr

GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline

Zacks
·
25 Apr

Goldman Sachs Adjusts Gilead Sciences Price Target to $100 From $97, Maintains Neutral Rating

MT Newswires Live
·
25 Apr

Q1 2025 Gilead Sciences Inc Earnings Call

Thomson Reuters StreetEvents
·
25 Apr

Gilead Shares Down 3.6% After Quarterly Revenue Miss

THOMSON REUTERS
·
25 Apr

Pre-Bell | US Stock Futures Slip; Alphabet Rises 4%; Meta, AppLovin up 3%; Tesla Jumps 1%; Intel Falls 7%

Tiger Newspress
·
25 Apr